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BACKGROUND:  Increased antibiotic resistant properties of 
pathogens has led to a pronounced search for new effective 
antibiotics from microbes in diverse ecological niches. This study 
focused on isolating actinomycetes from soil of reserved areas and 
profiling them for antibacterial potentials. 
METHODS: The isolates (IS-2, IS-4, IS-6, IS-10, IS-14) were 
assessed for antagonistic activity against ten multi-drug resistant 
bacterial strains (Gram positive and negative) by cross streak and 
well diffusion methods.  
RESULTS: During the primary screening, four of the isolates 
showed good antagonistic activity against the test strains. Notably, 
all the bacterial strains except Pseudomonas aeruginosa 
responded sensitively to at least one of the actinomycetes screened. 
The crude extracts of the secondary metabolites of the four 
actinomycetes (IS-2, IS-4, IS-6, IS-10) with considerably 
significant antagonistic activities inhibited the growth of all the 
bacterial strains efficiently. All the test bacterial strains were 
sensitive to at least one of the extracts at a concentration of 
100µg/ml. The minimum inhibitory concentration of the extracts 
against the isolates ranged from 12.5 - 25µg/ml. The crude 
extracts of IS-4 and IS-6 identified as Streptomyces glauciniger 
NBRC 100913 and Streptomyces griseoplanus NRRL-ISP 5009 by 
I6s rRNA sequencing, showed higher antibacterial activities 
against the bacterial strains. Significantly, the ethyl acetate crude 
extract of the actinomycetes demonstrated better antibacterial 
activities than the standard antibiotics (ofloxacin, 
amoxicillin/clavulanate, cefuroxime and ceftriaxone).  
CONCLUSION: This study reports remarkable anti-MRSA 
activities as well as broad spectrum antibacterial potentials of 
extracts of Streptomyces spp. worthy of further exploration. 





Soil, a mixture of organic matter, minerals, gases and liquids, is 
the largest source of microorganisms. The soil habitat offers a 
great avenue for the isolation of microorganisms such as 
actinomycetes, for the production of newer metabolites. The 
actinomycetes, a group of physiologically multifaceted, are 
filamentous bacteria found in both terrestrial and aquatic 
habitats. They are capable of producing a wide variety of 
secondary metabolites as a survival strategy (1,2). These 
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metabolites possess unique properties including 
antagonistic activities against microorganisms. 
Among the actinomycetes, Streptomyces 
receives the most attention because of their 
abundance in soil, wide phylogenetic spread and 
diversity of bioactive secondary metabolites (3). 
Interestingly, the majority of the antibiotic-
producing actinomycetes are found among these 
species. Microorganisms that thrive in extreme 
and diverse environments, including 
actinomycetes, are being investigated in recent 
researches. This focus is attributed to the array 
of physiological processes these organisms 
exhibit as adaptive measures for survivorship 
(4). Antimicrobial activities of secondary 
metabolites recovered from Streptomyces spp. 
isolated from reserved, unexplored or extreme 
environments have been reported (5,6,7,8). 
The increase in the rate of antimicrobial 
resistance exhibited by bacteria, especially the 
Gram negative populace, is a threat to public 
health (9). Of great concern, also, is the 
unavailability and non-production of new 
classes of antibiotics which could present wider 
antimicrobial spectrum on resistant strains of 
bacteria. This increasing prevalence of 
antimicrobial resistance (AMR) coupled with 
the dry antimicrobial development pipeline 
threatens the success and continuation of 
clinical medicine as we know it. The search for 
new effective antimicrobial compounds is 
therefore inevitable. As such, This study is 
therefore aimed to discover actinomycetes in 
soils from rivers, hospital environment, 
farmland, forest reserve areas and rotten wood 
deposits; and also evaluate the antibacterial 
potentials of the isolates. 
 
MATERIALS AND METHODS 
Collection of soil samples: Soil samples 
were collected from five different locations 
within Ilorin metropolis, Nigeria - hospital 
environment, river sediments, farmland, 
forest reserve areas and rotten wood 
deposits. The samples were scooped at 5-
15cm depth using a sterile hand trowel, 
transferred into sterile plastic containers and 
transported aseptically to the laboratory for 
physicochemical analysis and thereafter air-
dried for 3 days at room temperature.  
Physicochemical characteristics of soil 
samples: Temperature, pH, moisture 
content and soil organic matter of the soil 
samples were determined as described by 
(10,11,12,13). Soil parameters such as 
texture, particle size distribution and 
availability of macronutrients (Ca2+, Mg2+, 
K+) as well as exchangeable potassium and 
sodium were also determined (14). 
 
Isolation of actinomycetes from soil samples: 
Prior to isolation, all soil samples were air-dried 
for 3 days. Dried soil samples were serially 
diluted in sterile distilled water up to 10−5 
dilutions. Aliquots (0.1ml) from 10−3 and 10−5 
dilutions were spread evenly over the surface of 
sterile starch casein agar, Mueller Hinton agar 
and sterile nutrient agar + calcium chloride agar 
plates, and incubated aerobically at 30oC for 7 
days (8). The growth media were supplemented 
with amoxicillin (20µg/ml) and fluconazole 
(25µg/ml). The colonies were further grown on 
Yeast Extract-Malt Extract Agar (ISP-2 medium 
for clarity of pigmentation. Morphologically 
distinct colonies were further identified 
biochemically and by 16s rRNA sequencing. 
Primary screening of actinomycetes against 
bacterial strains: Primary screening of the 
selected actinomycetes for antibiotics potential 
against Klebsiella pneumoniae, Staphylococcus 
aureus ATCC 25923, Proteus mirabilis, 
Pseudomonas aeruginosa, clinical MRSA, MRSA 
ATCC 43300, Escherichia coli ATCC 25922, 
methicillin-sensitive Staphylococcus aureus 
NCTC 6571, Acinetobacter boumanii and ESBL-
producing Escherichia coli, were performed by 
cross streak method (15). Inoculum was prepared 
by growing cells in Mueller Hinton broth (Oxoid, 
UK) for 48h at 300C. A single vertical streak of 
the inoculum was inoculated on SCA (Oxoid, UK) 
and then incubated at 30o C for 48h. The plates 
were subsequently seeded by perpendicular streak 
of the overnight culture of the bacterial strains pre-
adjusted to 0.5 McFarland cell densities. The 
plates were then incubated for another 48h at 30o 
C. The microbial interactions were analyzed by 
determining the distance of inhibition measured in 
mm. 
Synthesis of metabolites from actinomycetes: 
Actinomycetes strains with considerable 
inhibitory activities were subjected to 
submerged fermentation. Pure cultures were 
inoculated into sterile fermentation medium 
(yeast extract, 3.0g; peptone, 3.0g; casein, 3.0g; 
soluble starch, 8.0g; glycerol, 3.0g; CaCO3, 
0.75g; K2HPO2, 0.5g; MgSO4.7H2O, 0.5g; 
NaCl, 12g; 250ml of distilled water; pH 7.4). 
The broth was incubated at 30oC for 7days on a 
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rotary shaker (200±5 rpm). After incubation, the 
broth was centrifuged at 5000rpm for 20minutes 
then filtered. Clear filtrates were tested for 
antibiotics activities (16). 
Extraction of active compounds: Equal 
volume (1:1) of filtrate and ethyl acetate (95%) 
solvent was mixed thoroughly on a rotary shaker 
for 24h and subsequently concentrated to crude 
with a rotary evaporator. The crude extracts 
were aseptically transferred into sterile sample 
bottles and refrigerated at 4oC until use (17). 
Secondary screening of actinomycetes against 
bacterial pathogens: Screening of the 
actinomycetes crude metabolite was performed by 
agar diffusion method. The ethyl acetate crude 
extracts reconstituted to a concentration of 
100µg/ml while DMSO was used as a control. 
Overnight cultures of the bacterial strains pre-
adjusted to 0.5 McFarland were seeded on the 
solidified Mueller Hinton agar (Oxoid, UK) plates, 
and holes of 6mm were bored on the agar. Each 
hole was filled with 100µl of the crude extracts, 
left for 30 mins at room temperature for diffusion 
and then incubated at 37o C for 20h. Zones of 
inhibitions were observed and recorded following 
incubation. All tests were done in triplicates (8). 
The minimum inhibitory/bactericidal 
concentrations of the extracts were determined by 
varying the concentrations (6.25-100 µg/ml) in 
Mueller Hinton broth. The medium was then 
inoculated with 100µl of the standardized bacterial 
culture and incubated at 37°C for 24h. Negative 
and positive controls of broth without extracts or 
organisms were set up. After incubation, the least 
concentration of extract showing no growth 
(turbidity) was taken as the MIC for the respective 
organism. MBC was deduced by streaking aliquots 
from the concentrations without growth on MHA 
and incubated at 37°C for 24h. The least 





Based on the morphological characteristics of 
the colonies on Starch Casein agar, five 
actinomycetes isolates were presumptively 
selected.  
Physicochemical parameters and elemental 
analysis of soil samples: The pH, temperature, 
organic matter and moisture content of the five 
samples showed similar values regardless of the 
variation in sampling sites, although the river 
sediments had much higher moisture content. 
The textural classes of the soils also varied as 
sandy loam (RS and RFA), loamy sand (HS), 
sand clay loam (VF) and loam (DWS). The most 
abundant element in all the soil samples was 
Phosphorus (1.81±0.02 - 3.05±0.04). Also, the 
soil samples from RFA and DWS were 
significantly richer in nutrients compared to 
other soil samples (Table 1). 
 
Antibiotics susceptibility profile of the 
bacterial strains: Using the CLSI (2018) 
interpretative guideline, all the isolates were 
resistant to augmentin, cefuroxime and 
ceftriaxone. The methicillin-sensitive 
Staphylococcus aureus strain and the 
clinical MRSA were however sensitive to 
ofloxacin while MRSA 43300, and Proteus 
mirabilis were resistant to all the tested 
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Figure 1: Antibiotics susceptibility profiling of bacterial pathogens 
 
Screening of actinomycetes against bacterial 
strains: The results of the primary and secondary 
screening of the actinomycetes and their 
secondary metabolites are presented in Figs. 2 
and 3. All the bacterial strains except 
Pseudomonas aeruginosa responded sensitively 
to at least one of the actinomycetes screened. 
Out of the five actinomycetes isolates (IS-2, IS-
4, IS-6, IS-10, IS-14) screened primarily for 
antibacterial potentials, IS-4 and IS-6 exerted 
more pronounced antagonistic activities against 
the test isolates while IS-14 showed the weakest 
activity. Notably, the Staphylococcus aureus 
strains and ESBL-producing E. coli strain 
showed considerable sensitivity to the 
actinomycetes with zones of inhibition ranging 
from 6 – 13mm. Also, IS-6 inhibited the growth 
of both Gram positive and negative bacteria 
with mean zones of inhibition of 8.5mm and 




Figure 2: Primary screening of actinomycetes against bacterial strain 
 
The crude extracts of the secondary 
metabolites of the four actinomycetes (IS-2, 
IS-4, IS-6, IS-10) with considerably significant 
antagonistic activities inhibited the growth of 
all the bacterial strains efficiently. All the test 
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of the extracts at a concentration of 100µg/ml 
(Figure 3A). Pseudomonas aeruginosa which 
was previously resistant at primary screening 
was prominently inhibited by all extracts with 
inhibition zones range of 13 – 19mm. Similar 
to the results of the primary screening, the 
crude extracts of IS-4 and IS-6 exhibited the 
strongest antibacterial activities against the 
bacterial pathogens. IS-6 extract remarkably 
inhibited the growth of all the isolates with 
zone of inhibition ranging from 10-20mm. 
Likewise, IS-4 extract showed inhibitory 
effects on all the isolates but Proteus 
mirabilis. At 50µg/ml concentration, 
Pseudomonas aeruginosa consistently showed 
sensitivity to all the extracts with mean zone 
of inhibition of 7.25mm. IS-6 extract still 
maintained the highest efficacy on all the 
isolates while IS-2 and IS-10 displayed the 
least activities on the isolates at this 
concentration (Figure 3B). 
Minimum inhibitory/bactericidal 
concentration: As shown in Table 2, the MIC 
for IS-2 extract against the two sensitive 
isolates, A. baumanii and P. aeruginosa was 
25µg/ml. For IS-4 extract, all the isolates 
except E. coli 25922 and MRSA 43300 had 
MIC of 25µg/ml. For IS-6 extract, MSSA 
6571, MRSA 43300, P. aeruginosa and clinical 
MRSA had MIC of 12.5µg/ml while the other 
isolates were least inhibited at 25µg/ml. 
Despite the low MIC, IS-4 extract had no 
bactericidal effect on any of the isolates. 
However, the IS-6 extract exhibited 
bactericidal actions at 25 – 100µg/ml against 
the isolates except ESBL-producing E. coli, A. 
baumanii, MRSA 43300 and Proteus 
mirabilis.  
Molecular characterization: The taxonomy 
and phylogeny of the isolates with the most 
pronounced activities, IS-4 ad IS-6, indicate 
that the isolates belong to the 
genus Streptomyces and designated 
as Streptomyces glauciniger NBRC 100913 
and Streptomyces griseoplanus NRRL-ISP 
5009, respectively. The partial 16s rDNA 
sequences showed 95% sequence similarity 
with Streptomyces avellaneus. The sequences 
were deposited in GenBank under the 
accession numbers NR11415 and NR041428. 
The phylogenetic tree shows the relationships 
between isolated actinomycetes and related 
strains. 
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The urgent need for new effective 
antimicrobial compounds is escalated by the 
increasing dominance of antimicrobial 
resistance, globally. The consequential effects 
on public health also spirals exploring reserved 
environments as possible reservoirs of sources 
of antimicrobial compounds. This study 
assessed the antibacterial potentials of 
Streptomyces species isolated from soils of 
reserved forest areas and wood decay deposits 
against bacterial strains of clinical importance. 
The physicochemical parameters of the soil 
samples support the optimal growth of 
mesophiles including actinomycetes. All the 
bacterial strains used exhibited decreased 
susceptibility to beta-lactam and 
cephalosporins. Drug-resistant strains of 
clinical pathogens, especially the Gram 
negative bacteria, largely portend the risk of 
disease outbreak with increased fatality due to 
their propensity of dissemination (18). 
Extensive resistance to cephalosporins and 
beta-lactams is being increasingly reported in 
clinical isolates across the globe (19,20). This 
resistance pattern has been identified as 
indicators of beta-lactamase production in the 
bacteria, which confers resistance to a wide 
range of antibiotics on them (21,22). 
Compared to the standard antibiotics, the 
five actinomycetes primarily screened 
inhibited the growth of the bacterial strains 
better although at varying extents. More 
significantly, the secondary screening of the 
ethylacetate extracts of the actinomycetes 
further affirmed the production of bioactive 
constituents in the isolates. Similar to the 
reports of Bhakyashree and Kannabiran (23), 
the extracts of the isolates, especially, 
Streptomyces glauciniger and Streptomyces 
griseoplanus, remarkably inhibited the growth 
of both methicillin resistant and sensitive 
Staphylococcus aureus strains. MRSA is one 
of the high priority pathogens causing life-
threatening diseases in invalids and 
convalescents. The significant anti-MRSA 
activities displayed therefore suggests the 
presence of explorable compounds in the 
secondary metabolites of these isolates to 
tackle this pathogen. Besides the prominent 
anti-MRSA activities, the extracts also arrayed 
a good spectrum of inhibitory activities on 
Gram negative bacteria including MDR P. 
aeruginosa, A, baumanii and P. mirabilis 
which are renowned for substantial drug 
resistance. 
The expansion of boundaries in the search 
for new antimicrobials with a focus on extreme 
and unusual environments largely targets 
actinomycetes. Not only because of their 
unique metabolic properties but also due to 
their adaptability to different environmental 
conditions such as neutral habitat which may 
gradually become saline, alkaline or acidic (4). 
The considerably low minimum inhibitory and 
bactericidal concentrations obtained for the 
extracts of Streptomyces glauciniger and 
Streptomyces griseoplanus in this study also 
reiterates the potency and broad-spectrum 
antagonistic properties of these metabolites. 
The limitation of this study is that we did not 
characterize the extracts of the isolates and as 
such cannot suggest the novelty of the 
bioactive compounds or compare them to 
existing ones. In future studies, we hope to 
further characterize the nature of these 
unknown antibiotics.  
This study reported the broad-spectrum 
antibacterial activities of extracts of secondary 
metabolites from Streptomyces glauciniger and 
Streptomyces griseoplanus isolated from soil, 
which corroborates the fact that actinomycetes 
represents a hub of untapped resources of 
translational benefits. Conclusively, the soil 
ecosystems of less explored areas serve as rich 
sources of actinomycetes that may be 
important sources of antibiotics. 
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